Related Experiment Video
Updated: Aug 19, 2025
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Arsenicum album Induces Cell Cycle Arrest and Apoptosis, and Inhibits Epithelial-Mesenchymal Transition in
Nilanjana Basu1, Manoj Garg1, Chanderdeep Tandon2
1Amity Institute Molecular Medicine & Stem Cell Research, Amity University, Noida, Uttar Pradesh, India.
Background:
Arsenic trioxide (As2O3) has been in therapeutic use since the 18th century for various types of cancers including skin and breast; however, it gained popularity following FDA approval for its use against acute promyelocytic leukemia. This present work was designed to evaluate the anti-cancer potential of a homeopathic potency of arsenic trioxide (Arsenicum album 6C) in hormone-dependent breast cancer.
Methods:
Breast cancer cells (MCF7) were treated with Arsenicum album (Ars 6C) to evaluate its anti-proliferative and apoptotic potential. We examined the effect of Ars 6C on the cell cycle, wound healing, reactive oxygen species (ROS) generation, and modulation of expression of key genes which are aberrant in cancer.
Results:
Treating breast cancer cells with Ars 6C halted the cell cycle at the sub-G0 and G2/M phases, which could be attributed to DNA damage induced by the generation of ROS. Apoptotic induction was associated with upregulation of Bax expression, with concurrent downregulation of the Bcl-2 gene. Ars 6C was also seen to reverse epithelial to mesenchymal transition and reduce the migration of breast cancer cells.
Conclusion:
The findings suggest that Ars has significant anti-proliferative and apoptotic potential against breast cancer cells. Further studies are required to elucidate the mechanism by which Ars exerts its effect in the in vivo setting.
Insights
This study shows that Arsenicum album 6C, a homeopathic potency of arsenic trioxide, effectively inhibits breast cancer cell proliferation and induces apoptosis. Further research is needed to understand its in vivo mechanisms.
Area of Science:
- Oncology
- Homeopathic Medicine
- Molecular Biology
Background:
- Arsenic trioxide (As2O3) has a long history in cancer therapy, gaining FDA approval for acute promyelocytic leukemia.
- This study investigates the anti-cancer effects of a homeopathic preparation, Arsenicum album 6C, on hormone-dependent breast cancer.
Purpose of the Study:
- To evaluate the anti-proliferative and apoptotic potential of Arsenicum album 6C in hormone-dependent breast cancer cells.
- To explore the effects of Arsenicum album 6C on cell cycle, migration, and gene expression in breast cancer.
Main Methods:
- MCF7 breast cancer cells were treated with Arsenicum album 6C.
- Assays included cell cycle analysis, wound healing, reactive oxygen species (ROS) generation, and gene expression profiling.
Main Results:
- Arsenicum album 6C induced cell cycle arrest at sub-G0 and G2/M phases, potentially via ROS-mediated DNA damage.
- Apoptosis was induced, evidenced by altered Bax and Bcl-2 gene expression.
- Epithelial-mesenchymal transition and cell migration were reduced by Arsenicum album 6C treatment.
Conclusions:
- Arsenicum album 6C demonstrates significant anti-proliferative and apoptotic effects on breast cancer cells.
- Further in vivo studies are necessary to fully elucidate the mechanisms of action.
Related Concept Videos
02:34Inhibition of Cdk Activity
02:38Mitogens and the Cell Cycle